Meropenem Dr. Friedrich Eberth

Meropenem, the active ingredient in Meropenem Dr. Friedrich Eberth, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats a range of serious bacterial infections in hospitalized patients.

GNH USA supplies Meropenem Dr. Friedrich Eberth as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: provides rapid bacterial clearance and reduces infection‑related mortality. - Complicated urinary tract infections: eradicates resistant Gram‑negative pathogens causing severe UTIs. - Hospital‑acquired pneumonia: targets multidrug‑resistant organisms in ventilated patients. - Severe sepsis and septic shock: delivers high‑dose bactericidal activity to control systemic infection. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat acute meningitis caused by susceptible strains.

Adverse reactions may occur with any antimicrobial therapy and should be monitored during treatment.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruption. - Headache: transient and usually resolves after therapy. - Elevated liver enzymes: transient increase in ALT/AST. - Injection site pain: discomfort at the IV site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption. - Anaphylaxis: acute hypersensitivity reaction requiring emergency care. - Severe hypersensitivity: including Stevens‑Johnson syndrome. - Renal toxicity: acute kidney injury in susceptible individuals. - Thrombocytopenia: low platelet counts requiring monitoring.

Careful assessment and monitoring are essential when using meropenem in high‑risk patients.

- Renal function assessment: adjust dosing in patients with impaired clearance. - Seizure risk evaluation: avoid in patients with a history of epilepsy or CNS disorders. - Hypersensitivity screening: discontinue if signs of severe allergic reaction appear. - Concomitant nephrotoxic drugs: monitor renal parameters closely. - Pregnancy and lactation: use only if the potential benefit outweighs the risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Valproic acid: meropenem reduces serum valproate levels, increasing seizure risk. - Other carbapenems: combined use may increase neurotoxicity. - Nephrotoxic agents (e.g., aminoglycosides): additive renal impairment.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR for potential anticoagulant effect changes. - Diuretics: may affect renal clearance of meropenem. - Other antibiotics (e.g., linezolid): assess for antagonistic effects on bacterial killing.